EUCODIS

Serial Number 98035730
Registration 7236632
700

Registration Progress

Application Filed
Jun 9, 2023
Under Examination
Approved for Publication
Sep 19, 2023
Published for Opposition
Sep 19, 2023
Registered
Dec 5, 2023

Trademark Image

EUCODIS

Basic Information

Serial Number
98035730
Registration Number
7236632
Filing Date
June 9, 2023
Registration Date
December 5, 2023
Published for Opposition
September 19, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 5, 2023
Registration
Registered
Classes
005

Rights Holder

Biosynth AG

03
Address
Rietlistrasse 4
Staad 9422
CH

Ownership History

Biosynth AG

Original Applicant
03
Staad CH

Biosynth AG

Owner at Publication
03
Staad CH

Biosynth AG

Original Registrant
03
Staad CH

Legal Representation

Attorney
Tara Reedy Sliva

USPTO Deadlines

Next Deadline
1589 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-12-05)
Due Date
December 05, 2029
Grace Period Ends
June 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Dec 5, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 5, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 19, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 19, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 30, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 11, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 9, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 13, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 13, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA)
First Use Anywhere: Apr 28, 2010
First Use in Commerce: Apr 28, 2010

Classification

International Classes
005